Search Results - "McCall, Mark J"

The translation of cell-based therapies: clinical landscape and manufacturing challenges by Heathman, Thomas RJ, Nienow, Alvin W, McCall, Mark J, Coopman, Karen, Kara, Bo, Hewitt, Christopher J

“…Cell-based therapies have the potential to make a large contribution toward currently unmet patient need and thus effective manufacture of these products is…”
Get full text

The Global Cell Therapy Industry Continues to Rise during the Second and Third Quarters of 2012 by Mason, Chris, McCall, Mark J., Culme-Seymour, Emily J., Suthasan, Shalini, Edwards-Parton, Simon, Bonfiglio, Gregory A., Reeve, Brock C.

“…During Q2-Q3 2012, the cell therapy industry benefited from a number of positive external influences including advantageous changes to future FDA regulation,…”
Get full text

From protocol to product: ventral midbrain dopaminergic neuron differentiation for the treatment of Parkinson's disease by Kusena, James Wt, Thomas, Robert J, McCall, Mark J, Wilson, Samantha L

“…Current cell therapy product limitations include the need for in-depth product understanding to ensure product potency, safety and purity. New technologies…”
Get full text

Distributed automated manufacturing of pluripotent stem cell products by Shariatzadeh, Maryam, Chandra, Amit, Wilson, Samantha L, McCall, Mark J, Morizur, Lise, Lesueur, Léa, Chose, Olivier, Gepp, Michael M., Schulz, André, Neubauer, Julia C., Zimmermann, Heiko, Abranches, Elsa, Man, Jennifer, O’Shea, Orla, Stacey, Glyn, Hewitt, Zoe, Williams, David J

“…Establishing how to effectively manufacture cell therapies is an industry-level problem. Decentralised manufacturing is of increasing importance, and its…”
Get full text

Cell therapy manufacturing value systems and cost analysis by McCall, Mark J S

“…Cell Therapies are promising clinical instruments with significant therapeutic potential and commercial promise. However, the industry engaged in their…”
Get full text